Trial intelligence / Profile preview

Adjunctive Stilnox for insomnia in patients with depression or dysthymia starting antidepressant therapy

2004-001967-24Phase 4Completed

Sponsor
Sanofi
Start
Jul 2004
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of zolpidem in Insomnia, major depressive disorder (MDD) and persistent depressive disorder (PDD) (2 arms), sponsored by Sanofi. Started Jul 2004; status: completed.

02

Drugs

zolpidem
03

Conditions

Insomniamajor depressive disorder (MDD)persistent depressive disorder (PDD)

Beyond the preview

Go deeper on 2004-001967-24.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2004-001967-24.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call